Theravance Biopharma, Inc.TBPHNASDAQ
Loading
Total value of everything the company owns
3Y CAGR
-7.2%/yr
vs +2.0%/yr prior
5Y CAGR
+0.7%/yr
Recent deceleration
Acceleration
-9.2pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $485.57M | +37.1% |
| 2024 | $354.16M | -7.3% |
| 2023 | $382.00M | -37.1% |
| 2022 | $607.40M | +62.1% |
| 2021 | $374.82M | -20.1% |
| 2020 | $469.06M | +14.7% |
| 2019 | $408.83M | -27.0% |
| 2018 | $560.24M | +26.9% |
| 2017 | $441.40M | -31.0% |
| 2016 | $639.25M | - |